- Home
- Publications
- Publication Search
- Publication Details
Title
Recent advances in CAR-T cells therapy for colorectal cancer
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-09-27
DOI
10.3389/fimmu.2022.904137
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Amplification of the CXCR3/CXCL9 axis via intratumoral electroporation of plasmid CXCL9 synergizes with plasmid IL-12 therapy to elicit robust anti-tumor immunity
- (2022) Jack Y. Lee et al. Molecular Therapy-Oncolytics
- Dual CAR-T cells to treat cancers co-expressing NKG2D and PD1 ligands in xenograft models of peritoneal metastasis
- (2022) Guangyi Jiang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Dopamine signaling promotes tissue-resident memory differentiation of CD8+ T cells and antitumor immunity
- (2022) Yingshi Chen et al. CANCER RESEARCH
- Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastases
- (2022) Kevin M Sullivan et al. GUT
- Trogocytosis and fratricide killing impede MSLN-directed CAR T cell functionality
- (2022) Esther Schoutrop et al. OncoImmunology
- IL-15 Upregulates Telomerase Expression and Potently Increases Proliferative Capacity of NK, NKT-Like, and CD8 T Cells
- (2021) Fiona Watkinson et al. Frontiers in Immunology
- Deletion of Cbl-b inhibits CD8+ T-cell exhaustion and promotes CAR T-cell function
- (2021) Jitendra Kumar et al. Journal for ImmunoTherapy of Cancer
- Development of CAR-T Cell Persistence in Adoptive Immunotherapy of Solid Tumors
- (2021) Jiaqiao Fan et al. Frontiers in Oncology
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The antitumor capacity of mesothelin-CAR-T cells in targeting solid tumors in mice
- (2021) Qian Zhang et al. Molecular Therapy-Oncolytics
- A Review of Colorectal Cancer in Terms of Epidemiology, Risk Factors, Development, Symptoms and Diagnosis
- (2021) Tomasz Sawicki et al. Cancers
- Anti-tumor effects of vascular endothelial growth factor/vascular endothelial growth factor receptor binding domain-modified chimeric antigen receptor T cells
- (2021) Haiyan Xing et al. CYTOTHERAPY
- High-dose IL-2/CD25 fusion protein amplifies vaccine-induced CD4+ and CD8+ neoantigen-specific T cells to promote antitumor immunity
- (2021) Rosmely Hernandez et al. Journal for ImmunoTherapy of Cancer
- Control of the activity of CAR-T cells within tumours via focused ultrasound
- (2021) Yiqian Wu et al. Nature Biomedical Engineering
- Improving the ability of CAR-T cells to hit solid tumors: Challenges and strategies
- (2021) Zheng-zheng Zhang et al. PHARMACOLOGICAL RESEARCH
- HER2-specific chimeric antigen receptor-T cells for targeted therapy of metastatic colorectal cancer
- (2021) Jie Xu et al. Cell Death & Disease
- Targeting Wnt Signaling in the Tumor Immune Microenvironment to Enhancing EpCAM CAR T-Cell therapy
- (2021) Weizhen Li et al. Frontiers in Pharmacology
- A four-chemokine signature is associated with a T cell-inflamed phenotype in primary and metastatic pancreatic cancer
- (2020) Joan Miguel Romero et al. CLINICAL CANCER RESEARCH
- Effect of CRISPR/Cas9-Mediated PD-1-Disrupted Primary Human Third-Generation CAR-T Cells Targeting EGFRvIII on In Vitro Human Glioblastoma Cell Growth
- (2020) Tsutomu Nakazawa et al. Cells
- IL7-IL12 Engineered Mesenchymal Stem Cells (MSCs) Improve A CAR T Cell Attack Against Colorectal Cancer Cells
- (2020) Andreas A. Hombach et al. Cells
- Recent advances in CAR-T cell engineering
- (2020) Ruihao Huang et al. Journal of Hematology & Oncology
- Biochemical Markers of Colorectal Cancer – Present and Future
- (2020) Wojciech Jelski et al. Cancer Management and Research
- Local delivery of CAR T cells targeting fibroblast activation protein is safe in patients with pleural mesothelioma: First report of FAPME, a phase I clinical trial
- (2020) S. Hiltbrunner et al. ANNALS OF ONCOLOGY
- Coexpression of IL7 and CCL21 Increases Efficacy of CAR-T Cells in Solid Tumors without Requiring Preconditioned Lymphodepletion
- (2020) Hong Luo et al. CLINICAL CANCER RESEARCH
- PD-1/PD-L1 axis importance and tumor microenvironment immune cells
- (2020) Parisa Lotfinejad et al. LIFE SCIENCES
- Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
- (2019) Xianjie Jiang et al. Molecular Cancer
- Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer
- (2019) A B Schrock et al. ANNALS OF ONCOLOGY
- Pharmacological inhibition of β-catenin/BCL9 interaction overcomes resistance to immune checkpoint blockades by modulating Treg cells
- (2019) M. Feng et al. Science Advances
- HITM-SIR: phase Ib trial of intraarterial chimeric antigen receptor T-cell therapy and selective internal radiation therapy for CEA+ liver metastases
- (2019) Steven C. Katz et al. CANCER GENE THERAPY
- Blocking CD30 on T Cells by a Dual Specific CAR for CD30 and Colon Cancer Antigens Improves the CAR T Cell Response against CD30− Tumors
- (2019) Andreas A. Hombach et al. MOLECULAR THERAPY
- Significantly increased anti-tumor activity of carcinoembryonic antigen-specific chimeric antigen receptor T cells in combination with recombinant human IL-12
- (2019) Xiaowei Chi et al. Cancer Medicine
- MicroRNA-153 Decreases Tryptophan Catabolism and Inhibits Angiogenesis in Bladder Cancer by Targeting Indoleamine 2,3-Dioxygenase 1
- (2019) Wentao Zhang et al. Frontiers in Oncology
- Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR
- (2019) Sara Ghorashian et al. NATURE MEDICINE
- Biology and therapeutic potential of interleukin-10
- (2019) Margarida Saraiva et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The Vascular Disrupting Agent CA4P Improves the Antitumor Efficacy of CAR-T Cells in Preclinical Models of Solid Human Tumors
- (2019) Changwen Deng et al. MOLECULAR THERAPY
- CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma
- (2019) Bryan D. Choi et al. Journal for ImmunoTherapy of Cancer
- DCLK1 Monoclonal Antibody-Based CAR-T Cells as a Novel Treatment Strategy against Human Colorectal Cancers
- (2019) Sripathi M. Sureban et al. Cancers
- Extracellular domain of EpCAM enhances tumor progression through EGFR signaling in colon cancer cells
- (2018) Kang-Hao Liang et al. CANCER LETTERS
- miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy
- (2018) Qian Huang et al. Journal of Hematology & Oncology
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- Intratumoral Delivery of Interferonγ-Secreting Mesenchymal Stromal Cells Repolarizes Tumor-Associated Macrophages and Suppresses Neuroblastoma Proliferation In Vivo
- (2018) Theresa Relation et al. STEM CELLS
- CAR-T cells: the long and winding road to solid tumors
- (2018) Maria Michela D’Aloia et al. Cell Death & Disease
- Genetic Mechanisms of Immune Evasion in Colorectal Cancer
- (2018) Catherine S. Grasso et al. Cancer Discovery
- Human GUCY2C-Targeted Chimeric Antigen Receptor (CAR)-Expressing T Cells Eliminate Colorectal Cancer Metastases
- (2018) Michael S. Magee et al. Cancer Immunology Research
- Intra-tumoral delivery of CXCL11 via a vaccinia virus, but not by modified T cells, enhances the efficacy of adoptive T cell therapy and vaccines
- (2018) Edmund K. Moon et al. OncoImmunology
- CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial
- (2018) Yao Wang et al. OncoImmunology
- CD19 CAR T Cells Expressing IL-12 Eradicate Lymphoma in Fully Lymphoreplete Mice through Induction of Host Immunity
- (2018) Gray Kueberuwa et al. Molecular Therapy-Oncolytics
- Switchable CAR-T cells mediate remission in metastatic pancreatic ductal adenocarcinoma
- (2018) Deepak Raj et al. GUT
- Targeting the paracrine hormone-dependent guanylate cyclase/cGMP/phosphodiesterases signaling pathway for colorectal cancer prevention
- (2018) N.S. Yarla et al. SEMINARS IN CANCER BIOLOGY
- Recent advances in CAR T-cell toxicity: Mechanisms, manifestations and management
- (2018) Jennifer N. Brudno et al. BLOOD REVIEWS
- Teaching an old dog new tricks: next-generation CAR T cells
- (2018) Nicholas Tokarew et al. BRITISH JOURNAL OF CANCER
- CRISPR/Cas9-mediated PD-1 disruption enhances human mesothelin-targeted CAR T cell effector functions
- (2018) Wanghong Hu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- HER2-targeted therapy: an emerging strategy in advanced colorectal cancer
- (2018) Anna La Salvia et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- IDO1: An important immunotherapy target in cancer treatment
- (2017) Fangxuan Li et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Phase I Escalating-Dose Trial of CAR-T Therapy Targeting CEA + Metastatic Colorectal Cancers
- (2017) Chengcheng Zhang et al. MOLECULAR THERAPY
- Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9
- (2017) Jiangtao Ren et al. Protein & Cell
- Trial Watch: Adoptively transferred cells for anticancer immunotherapy
- (2017) Carole Fournier et al. OncoImmunology
- CAR T-cell intrinsic PD-1 checkpoint blockade: A two-in-one approach for solid tumor immunotherapy
- (2017) Nan Chen et al. OncoImmunology
- Armored CAR T-cells: utilizing cytokines and pro-inflammatory ligands to enhance CAR T-cell anti-tumour efficacy
- (2016) Oladapo O. Yeku et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Immunotherapy and tumor microenvironment
- (2016) Haidong Tang et al. CANCER LETTERS
- FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3–CCL2 Signaling
- (2016) Xuguang Yang et al. CANCER RESEARCH
- Interaction of MSC with tumor cells
- (2016) Catharina Melzer et al. Cell Communication and Signaling
- Mesothelin Immunotherapy for Cancer: Ready for Prime Time?
- (2016) Raffit Hassan et al. JOURNAL OF CLINICAL ONCOLOGY
- CD133, Selectively Targeting the Root of Cancer
- (2016) Jörg Schmohl et al. Toxins
- 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors
- (2015) Adrienne H Long et al. NATURE MEDICINE
- Microenvironmental regulation of therapeutic response in cancer
- (2015) Florian Klemm et al. TRENDS IN CELL BIOLOGY
- Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors
- (2015) A. Morello et al. Cancer Discovery
- Enhancement of the in vivo persistence and antitumor efficacy of CD19 chimeric antigen receptor T cells through the delivery of modified TERT mRNA
- (2015) Yun Bai et al. Cell Discovery
- Macrophage IL-10 Blocks CD8+ T Cell-Dependent Responses to Chemotherapy by Suppressing IL-12 Expression in Intratumoral Dendritic Cells
- (2014) Brian Ruffell et al. CANCER CELL
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-melanoma activity of T cells redirected with a TCR-like chimeric antigen receptor
- (2014) Ge Zhang et al. Scientific Reports
- The Nonsignaling Extracellular Spacer Domain of Chimeric Antigen Receptors Is Decisive for In Vivo Antitumor Activity
- (2014) M. Hudecek et al. Cancer Immunology Research
- Differentiation of CD8 memory T cells depends on Foxo1
- (2013) Rodrigo Hess Michelini et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
- (2012) Douglas Hanahan et al. CANCER CELL
- Targeted immunotherapy of cancer with CAR T cells: achievements and challenges
- (2012) Grazyna Lipowska-Bhalla et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Modulation of Microenvironment Acidity Reverses Anergy in Human and Murine Tumor-Infiltrating T Lymphocytes
- (2012) A. Calcinotto et al. CANCER RESEARCH
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer
- (2011) Ole Audun Werner Haabeth et al. Nature Communications
- Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanism
- (2011) Sripathi M Sureban et al. JOURNAL OF NANOBIOTECHNOLOGY
- Cbl-b and Itch: Key Regulators of Peripheral T-cell Tolerance
- (2010) K. Venuprasad CANCER RESEARCH
- The Optimal Antigen Response of Chimeric Antigen Receptors Harboring the CD3 Transmembrane Domain Is Dependent upon Incorporation of the Receptor into the Endogenous TCR/CD3 Complex
- (2010) J. S. Bridgeman et al. JOURNAL OF IMMUNOLOGY
- Blimp-1 Transcription Factor Is Required for the Differentiation of Effector CD8+ T Cells and Memory Responses
- (2009) Axel Kallies et al. IMMUNITY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started